Co-Authors
This is a "connection" page, showing publications co-authored by Gabriella Fabbrocini and Katharina Hansel.
Connection Strength
0.473
-
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167.
Score: 0.241
-
Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035.
Score: 0.060
-
Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST). Ital J Dermatol Venerol. 2021 Apr; 156(2):115-117.
Score: 0.059
-
SARS-CoV-2 vaccines and biological treatments: dermatological perspectives. Ital J Dermatol Venerol. 2021 Apr; 156(2):118-120.
Score: 0.059
-
Dupilumab and COVID-19: What should we expect? Dermatol Ther. 2020 Jul; 33(4):e13502.
Score: 0.055